Written by Mr Jai Seth, Consultant Urological Surgeon
Specialist in bladder, prostate and urinary health, London · Full biography · Publications
Overactive bladder (OAB) is a common condition that affects approximately one in six women. If you find yourself rushing to the toilet, going too frequently, or experiencing leaks before you can get there, you are not alone. The good news is that OAB is highly treatable, and most women can achieve significant improvement in their symptoms.
What Is Overactive Bladder?
Overactive bladder is a syndrome characterised by: - Urgency: A sudden, compelling need to urinate that is difficult to defer - Frequency: Needing to urinate more than eight times in 24 hours - Nocturia: Waking up one or more times at night to urinate - Urge incontinence: Leaking urine before reaching the toilet (this may or may not be present)
OAB occurs when the bladder muscle (detrusor) contracts involuntarily, even when the bladder is not full. This creates the sensation of urgency and can lead to leakage.
Why Is OAB More Common in Women?
Several factors make women more susceptible to overactive bladder:
Hormonal Changes: The decline in oestrogen during perimenopause and menopause affects the bladder and urethra, making OAB symptoms more common in midlife and beyond.
Pregnancy and Childbirth: The physical stress of pregnancy and vaginal delivery can weaken pelvic floor muscles and affect bladder control. However, OAB can occur in women who have never been pregnant.
Pelvic Organ Prolapse: When pelvic organs drop from their normal position, they can affect bladder function and contribute to OAB symptoms.
Hysterectomy: Some women notice bladder changes after hysterectomy, though this is not universal.
The Impact on Quality of Life
OAB is not just an inconvenience – it can significantly affect your quality of life. Many women with OAB report: - Anxiety about being too far from a toilet - Limiting social activities, travel, and exercise - Sleep disruption due to night-time waking - Impact on intimate relationships - Reduced confidence and self-esteem
It is important to understand that OAB is a medical condition, not a normal part of ageing, and effective treatments are available.
First-Line Treatments: Lifestyle Modifications
Before considering medications or procedures, several lifestyle changes can make a significant difference:
Fluid Management: Drinking too much or too little can worsen symptoms. Aim for 1.5 to 2 litres per day, and reduce evening intake to help with nocturia.
Reduce Bladder Irritants: Caffeine, alcohol, artificial sweeteners, and carbonated drinks can irritate the bladder. Reducing or eliminating these may help.
Maintain a Healthy Weight: Excess weight puts pressure on the bladder and pelvic floor. Even modest weight loss can improve symptoms.
Quit Smoking: Smoking irritates the bladder and causes coughing, which can worsen incontinence.
Manage Constipation: A full bowel presses on the bladder and can worsen urgency.
Bladder Training
Bladder training is a behavioural technique that teaches you to gradually increase the time between toilet visits. By resisting the urge to go immediately and using distraction techniques, you can retrain your bladder to hold more urine and reduce urgency. This approach is often combined with a bladder diary to track progress.
Pelvic Floor Exercises
Strengthening your pelvic floor muscles can help control urgency and prevent leakage. A specialist physiotherapist can teach you the correct technique, as many women inadvertently do these exercises incorrectly. Consistency is key – it typically takes 8 to 12 weeks to see improvement.
Medication Options
When lifestyle changes and behavioural therapies are not sufficient, medications can be very effective:
Anticholinergics: These medications (such as oxybutynin, tolterodine, solifenacin, and fesoterodine) work by blocking the nerve signals that cause the bladder to contract involuntarily. They are effective for many women but can cause side effects including dry mouth, constipation, and blurred vision.
Beta-3 Agonists: Mirabegron is a newer medication that works differently, relaxing the bladder muscle. It may have fewer side effects than anticholinergics and is often well-tolerated.
Topical Oestrogen: For post-menopausal women, vaginal oestrogen (cream, pessary, or ring) can help improve bladder symptoms by restoring the health of the vaginal and urethral tissues.
Bladder Botox Injections
For women who have not responded to or cannot tolerate medications, botulinum toxin (Botox) injections into the bladder wall can be highly effective. The procedure is performed as a day case under local anaesthetic and typically provides relief for 6 to 12 months before needing to be repeated.
Botox works by blocking the nerve signals that cause involuntary bladder contractions. Studies show that 70 to 80 percent of women experience significant improvement. The main potential side effect is temporary difficulty emptying the bladder, which may require short-term self-catheterisation.
Nerve Stimulation Therapies
Percutaneous Tibial Nerve Stimulation (PTNS): This involves inserting a fine needle near the ankle and delivering gentle electrical stimulation to the nerves that control bladder function. Treatment is given weekly for 12 weeks, with maintenance sessions as needed.
Sacral Neuromodulation: For severe cases that have not responded to other treatments, a small device similar to a pacemaker can be implanted to regulate the nerve signals between the bladder and brain.
When to Seek Help
Many women live with OAB symptoms for years — sometimes because they are embarrassed, sometimes because they assume it is a feature of getting older. Neither assumption reflects what current treatment can offer.
How to start
A conversation with a GP is the usual entry point. It is often brief and focused — symptoms, a urine test, and in many cases a referral for bladder diary and continence physiotherapy before medication or further investigation is considered. That pathway runs through NHS urology services. A private consultation with a urologist or urogynaecologist is an alternative route. Either way, earlier assessment usually shortens the route to the treatment that suits you.
References
- Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20.
- Gormley EA, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012 Dec;188(6 Suppl):2455-63.
- Chapple CR, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008 Sep;54(3):543-62.
- Nitti VW, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun;189(6):2186-93.